tiprankstipranks
Urogen Pharma (URGN)
NASDAQ:URGN
US Market
URGN
Urogen Pharma
RESEARCH TOOLSreports
Want to see URGN full AI Analyst Report?

Urogen Pharma (URGN) Income Statement

655 Followers

Urogen Pharma Income Statement

Last quarter (Q4 2025), Urogen Pharma's total revenue was $37.84M, an increase of 54.03% from the same quarter last year. In Q4, Urogen Pharma's net income was $-26.36M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 109.79M$ 90.40M$ 82.71M$ 64.36M$ 48.04M
Gross Profit
$ 97.34M$ 81.52M$ 73.35M$ 56.70M$ 42.88M
Operating Expenses
$ 222.20M$ 178.30M$ 138.89M$ 135.74M$ 135.18M
Depreciation and Amortization
$ 2.41M$ 329.00K$ 1.71M$ 1.82M$ 831.00K
EBITDA
$ -135.66M$ -95.35M$ -60.35M$ -76.21M$ -91.46M
Operating Income
$ -124.86M$ -96.78M$ -65.54M$ -79.04M$ -92.29M
Other Income/Expenses
$ -28.55M$ -27.26M$ -32.79M$ -28.99M$ -17.08M
Pretax Income
$ -153.42M$ -124.04M$ -98.32M$ -108.03M$ -109.37M
Net Income
$ -153.49M$ -126.87M$ -102.24M$ -109.78M$ -110.82M
Per Share Metrics
Basic EPS
$ -3.19$ -2.96$ -3.55$ -4.79$ -4.96
Diluted EPS
$ -3.19$ -2.96$ -3.55$ -4.79$ -4.96
Weighted Average Shares Outstanding
 48.12M 42.88M 28.83M 22.81M 22.35M
Weighted Average Shares Outstanding (Diluted)
 48.12M 42.88M 28.83M 22.81M 22.35M
Currency in USD

Urogen Pharma Earnings and Revenue History